MyCelx Technologies Corporation Dealings by Directors (5388E)
March 11 2022 - 7:10AM
UK Regulatory
TIDMMYX TIDMTTM
RNS Number : 5388E
MyCelx Technologies Corporation
11 March 2022
11 March 2022
MYCELX Technologies Corporation
Dealings by Directors
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water and clean air technology company, announces, further to
the Placing and Subscription this morning, the following
participation by Directors of the Company.
Director Shares held New Shares Purchased Shares held Percentage
prior to Admission post Admission of Enlarged
Issued Share
Capital
Thomas Lamb 25,000 267,175 292,175 1.28%
-------------------- --------------------- ---------------- --------------
Connie Mixon 2,514,469 38,167 2,552,636 11.18%
-------------------- --------------------- ---------------- --------------
Andre Schnabl 8,246 38,167 46,413 0.20%
-------------------- --------------------- ---------------- --------------
Total Voting Rights
In conformity with the FCA's Disclosure Guidance and
Transparency Rules (the "Rules") provision 5.6.1, the Company would
like to notify the market that following Admission on 21 March 2022
its issued share capital will consist of 22,828,023 Common Shares
of US$0.025 each.
Shareholders should use 22,828,023 as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the Rules.
Terms and definitions used in this announcement shall have the
same meaning as ascribed to them in the Placing and Subscription
Announcement released at 7:00 a.m. on 11 March 2022, unless the
context requires otherwise.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity, Nominated Adviser
Henry Fitzgerald-O'Connor Tel: + 44 20 7523 8000
Gordon Hamilton
Notifications of transactions of persons discharging managerial
responsibility or connected persons
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Thomas Lamb
-------------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Director
-------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mycelx Technologies Corporation
-------------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-------------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument USU624551235
Identification code
-------------------------------- ---------------------------------------
b) Nature of the transaction Purchase of Common Shares
-------------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.50 267,175
----------
-------------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------------- ---------------------------------------
e) Date of the transaction 11 March 2022
-------------------------------- ---------------------------------------
f) Place of the transaction London Stock Exchange
-------------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Connie Mixon
-------------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Director
-------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mycelx Technologies Corporation
-------------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-------------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument USU624551235
Identification code
-------------------------------- ---------------------------------------
b) Nature of the transaction Purchase of Common Shares
-------------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.50 38,167
----------
-------------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------------- ---------------------------------------
e) Date of the transaction 11 March 2022
-------------------------------- ---------------------------------------
f) Place of the transaction London Stock Exchange
-------------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Andre Schnabl
-------------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Director
-------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mycelx Technologies Corporation
-------------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-------------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument USU624551235
Identification code
-------------------------------- ---------------------------------------
b) Nature of the transaction Purchase of Common Shares
-------------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.50 38,167
----------
-------------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------------- ---------------------------------------
e) Date of the transaction 11 March 2022
-------------------------------- ---------------------------------------
f) Place of the transaction London Stock Exchange
-------------------------------- ---------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHJBMJTMTMBBIT
(END) Dow Jones Newswires
March 11, 2022 08:10 ET (13:10 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024
